QuidelOrtho Corporation QDEL Domestic — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by QuidelOrtho Corporation in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about QuidelOrtho Corporation's domestic — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is QuidelOrtho Corporation's domestic — total revenues?
- QuidelOrtho Corporation (QDEL) reported domestic — total revenues of $359.15M in Q4 2025.
- How has QuidelOrtho Corporation's domestic — total revenues changed year-over-year?
- QuidelOrtho Corporation's domestic — total revenues decreased by 8.4% year-over-year, from $392.2M to $359.15M.
- What is the long-term trend for QuidelOrtho Corporation's domestic — total revenues?
- Over 3 years (2022 to 2025), QuidelOrtho Corporation's domestic — total revenues has grown at a -16.3% compound annual growth rate (CAGR), from $2.45B to $1.44B.
- What does domestic — total revenues mean?
- Measures the total gross income generated from the sale of diagnostic testing solutions and services within the domestic market. This figure reflects the company's market penetration and demand for its immunoassay, molecular, and clinical chemistry products in its primary geographic region. It is a critical indicator of the company's ability to maintain its domestic market share and revenue stability.